EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression

[1]  E. Rosenthal,et al.  Fibroblast Growth Factor Receptor Mediates Fibroblast-Dependent Growth in EMMPRIN-Depleted Head and Neck Cancer Tumor Cells , 2011, Molecular Cancer Research.

[2]  E. Genden,et al.  Head and neck squamous cell carcinoma: new translational therapies. , 2010, The Mount Sinai journal of medicine, New York.

[3]  R. Porcher,et al.  EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2 , 2010, PloS one.

[4]  J. Vermorken,et al.  Advances in the systemic treatment of head and neck cancers , 2010, Current opinion in oncology.

[5]  T. Kanekura,et al.  CD147/basigin promotes progression of malignant melanoma and other cancers. , 2010, Journal of dermatological science.

[6]  Shellaine R. Frazier,et al.  Urinary-Type Plasminogen Activator Receptor/α3β1 Integrin Signaling, Altered Gene Expression, and Oral Tumor Progression , 2010, Molecular Cancer Research.

[7]  G. Millot,et al.  EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. , 2009, Blood.

[8]  R. Jaeger,et al.  Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and β1 integrin , 2009, Tumor Biology.

[9]  E. Rosenthal,et al.  Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. , 2008, Archives of otolaryngology--head & neck surgery.

[10]  A. Atakilit,et al.  EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. , 2008, Anticancer research.

[11]  M. Slomiany,et al.  Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[12]  S. Mourah,et al.  Role of Emmprin/CD147 in Tissue Remodeling , 2008, Connective tissue research.

[13]  M. Stack,et al.  Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. , 2007, The Biochemical journal.

[14]  C. Lebbé,et al.  Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. , 2007, Cancer research.

[15]  Jing Lin,et al.  A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. , 2006, Cancer research.

[16]  A. Ziober,et al.  The extracellular matrix in oral squamous cell carcinoma: Friend or foe? , 2006, Head & neck.

[17]  H. Iwasaki,et al.  Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression , 2006, Pathology international.

[18]  B. Nielsen,et al.  Expression of plasminogen activator inhibitor‐1, urokinase receptor and laminin γ‐2 chain is an early coordinated event in incipient oral squamous cell carcinoma , 2006, International journal of cancer.

[19]  Jean Wu,et al.  Increased EMMPRIN (CD 147) expression during oral carcinogenesis. , 2006, Experimental and molecular pathology.

[20]  P. Lacal,et al.  An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells. , 2005, International journal of oncology.

[21]  Yi Tang,et al.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. , 2005, Cancer research.

[22]  T. Hoang‐Xuan,et al.  EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. , 2005, Biochimie.

[23]  Li Yan,et al.  Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression , 2005, Thrombosis and Haemostasis.

[24]  C. R. Leemans,et al.  Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. , 2004, Journal of the National Cancer Institute.

[25]  Makoto Ohnishi,et al.  Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis , 2003, International journal of cancer.

[26]  E. Rosenthal,et al.  Expression of Extracellular Matrix Metalloprotease Inducer in Laryngeal Squamous Cell Carcinoma , 2003, The Laryngoscope.

[27]  T. Muramatsu,et al.  Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. , 2003, Histology and histopathology.

[28]  B. Toole.  Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. , 2003, Current topics in developmental biology.

[29]  M. Stack,et al.  Loss of adhesion‐regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma , 2002, Cancer.

[30]  T. Kanekura,et al.  Basigin (cd147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts , 2002, International journal of cancer.

[31]  B. Toole,et al.  Tumorigenic potential of extracellular matrix metalloproteinase inducer. , 2001, The American journal of pathology.

[32]  X. Li,et al.  Expression of emmprin by oral squamous cell carcinoma. , 2000, International journal of cancer.

[33]  H. Guo,et al.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.

[34]  Sidney E. Chang,et al.  DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non‐malignant phenotype , 1992, International journal of cancer.